AIM ImmunoTech Inc. (AIM) — Dilution Risk Analysis
Current Snapshot
AIM ImmunoTech Inc. (AIM) has a DilutionWatch score of 76/10 and is classified as CRITICAL risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 76/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: 8-K 3, EFFECT 2, XBRL 2.
| Form | Filed | Accession |
|---|---|---|
| 8-K | 2026-08-05 | 0001493152-26-036104 |
| 8-K | 2026-07-16 | 0001493152-26-033514 |
| EFFECT | 2026-06-23 | 9999999995-26-002094 |
| EFFECT | 2026-06-16 | 9999999995-26-002022 |
| 8-K | 2026-06-11 | 0001493152-26-028283 |
| xbrl | 2026-01-20 | xbrl-7292-xbrl_warrant |
| xbrl | 2020-12-31 | xbrl-7292-xbrl_convertible |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 14 months | Source |
| Three-year share count growth | 1458.21% | Source |
DilutionWatch Analysis
- Risk Level
- CRITICAL (Score: 76/10) Source
- Cash Runway
- 14 months Source
- Share Count Growth (3-Year)
- 1458.21% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.